| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $17M | — | $20M | — | -15.8% |
| Op. Income | $15M | — | $18M | — | -16.7% |
| Gross Margin | 88.2% | — | 92.5% | — | -4.3pp |
| Net Margin | 77.4% | — | 84.9% | — | -7.6pp |
| EPS (Diluted) | $1.23 | — | $1.62 | — | -24.1% |
| Free Cash Flow | $11M | — | $13M | — | -17.3% |
| Item | Amount |
|---|---|
| REVENUE | $17M |
| Cost of Revenue | $2M |
| GROSS PROFIT | $15M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | -$298.9K |
| Operating Expenses | -$298.9K |
| Cost & Expenses | $2M |
| OPERATING INCOME | $15M |
| Interest Income | $18M |
| Interest Expense | $2M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $14M |
| Income Tax Expense | $350.9K |
| Net Income from Continuing Ops | $13M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $13M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $13M |
| D&A | $0 |
| EBIT | $15M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $17M |
| Cost of Revenue | $2M |
| GROSS PROFIT | $15M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | -$298.9K |
| Operating Expenses | -$298.9K |
| Cost & Expenses | $2M |
| OPERATING INCOME | $15M |
| Interest Income | $18M |
| Interest Expense | $2M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $14M |
| Income Tax Expense | $350.9K |
| Net Income from Continuing Ops | $13M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $13M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $13M |
| D&A | $0 |
| EBIT | $15M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $13M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$2M |
| Change in Working Capital | -$245.3K |
| OPERATING CASH FLOW | $11M |
| Capital Expenditure | $4 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$60M |
| Sales/Maturities of Investments | $58M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$2M |
| Net Debt Issuance | $14M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$212.8K |
| NET CASH FROM FINANCING | -$2M |
| FREE CASH FLOW | $11M |
| Net Change in Cash | $7M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $14M |
| Short-Term Investments | $0 |
| Net Receivables | $3M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $17M |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $191M |
| Tax Assets | $0 |
| Other Non-Current Assets | $446.8K |
| TOTAL NON-CURRENT ASSETS | $192M |
| TOTAL ASSETS | $208M |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $37M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $17.9K |
| Other Non-Current Liabilities | $7M |
| TOTAL NON-CURRENT LIABILITIES | $45M |
| TOTAL LIABILITIES | $45M |
| Common Stock | $107.6K |
| Additional Paid-In Capital | $146M |
| Retained Earnings | $18M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $164M |
| Minority Interest | $0 |
| TOTAL EQUITY | $164M |
| TOTAL LIABILITIES & EQUITY | $208M |
| Total Debt | $37M |
| Net Debt | $24M |
